Strengthen your approach to inflammatory bowel disease (IBD) care with expert-led strategies you can apply immediately with “Conversations in tailoring treatment of complex patients with inflammatory bowel disease.” This focused course delivers real-world solutions to complex treatment decisions — whether you’re managing new diagnoses, navigating treatment escalation, or optimizing long-term outcomes for patients with Crohn’s disease and ulcerative colitis.
Led by nationally recognized IBD experts, Raymond K. Cross, MD and Millie D. Long, MD, MPH, this program gives you immediate access to current best practices and evidence-based guidance that can elevate your decision-making and patient communication. Each module is designed to help you gain clarity in the face of evolving therapies and complex cases.
Meet the experts
Dr. Cross is a nationally recognized leader in IBD care and serves as the director of the IBD program at the University of Maryland and practices at Maryland Digestive Health. With extensive clinical and research experience, Dr. Cross focuses on improving quality of life for IBD patients and advancing treatment strategies through clinical innovation.
Dr. Long is a professor of medicine at the University of North Carolina and co-director of the UNC IBD Center. In addition to being a researcher and educator, her work bridges the gap between clinical evidence and patient-centered care, particularly in areas like IBD prevention and long-term outcomes.
Developed with you in mind
We know that you’re busy but won’t compromise on quality, which is why this course features:
- Self-paced, expert-led content: Dive into high-impact modules focused on current IBD treatments, biologic therapies, and patient-centered decision-making.
- 1.0 CME credit: Fulfill continuing education requirements while deepening your clinical skills in IBD care.
- On-demand convenience: Access the course anytime, anywhere, and revisit materials when you need a refresher.
- Real-world relevance: Learn practical strategies informed by leaders who care for IBD patients each day.
This program is supported by an educational grant from Takeda Pharmaceuticals USA, Inc. It was developed through a collaboration between AGA and Paradigm Medical Communications, LLC.
